Lack of metabolic effects of a triphasic formulation containing norethindrone in normal women studied prospectively.
作者信息
Toth E L, Ryan E A
机构信息
Department of Medicine, University of Alberta, Edmonton, Canada.
出版信息
Contraception. 1988 Jun;37(6):549-54. doi: 10.1016/0010-7824(88)90001-7.
PMID:3293908
Abstract
The glucose and insulin responses to oral glucose tolerance tests and lipid values in normal women taking a triphasic pill containing norethindrone (Ortho 7/7/7) were performed. After three months, no significant changes in these metabolic indices were found. These results confirm and expand the knowledge regarding the metabolic safety of norethindrone-containing triphasic formulations.
摘要
Zotero 插件